Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» acute lung injury
acute lung injury
Theravance Biopharma doses first patient in phase 2 Covid-19 trial with JAKi inhibitor TD-0903
Pharmaceutical Business Review
Fri, 06/26/20 - 09:42 am
Theravance
COVID-19
clinical trials
acute lung injury
TD-0903